We also showed that the levels of plasma IGF-1R in pancreatic cancer patients were comparable to that in healthy volunteers, but higher than that in patients with chronic pancreatitis, other pancreatic tumors and pancreatic neuroendocrine tumors, and displayed values for distinguishing pancreatic lesions. Here, IGF1R is linked to chronic pancreatitis.